6
Views
5
CrossRef citations to date
0
Altmetric
Gene Expression

Transforming Growth Factor βl-Responsive Element: Closely Associated Binding Sites for USF and CCAAT-Binding Transcription Factor-Nuclear Factor I in the Type 1 Plasminogen Activator Inhibitor Gene

, , , , &
Pages 1846-1855 | Received 06 Jan 1992, Accepted 24 Jan 1992, Published online: 31 Mar 2023

REFERENCES

  • Andreasen, P. A., B. Georg, L. R. Lund, A. Riccio, and S. Stacey. 1990. Plasminogen activator inhibitors: hormonally regulated serpins. Mol. Cell. Endocrinol. 68:1–19.
  • Battegay, E. J., E. W. Raines, R. A. Seifert, D. F. Bowen-Pope, and R. Ross. 1990. TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515–524.
  • Blackwell, T. K., L. Kretzner, E. Μ. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-myc protein. Science 250:1149–1151.
  • Blackwell, T. K., and H. Weintraub. 1990. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250:1104–1110.
  • Blackwood, E. Μ., and R. N. Eisenman. 1991. Max: a helix-loop- helix zipper protein that forms a sequence-specific DNA-binding complex with myc. Science 251:1211–1217.
  • Blasi, F., J.-D. Vassalli, and K. Dano. 1987. Urokinase-type plasminogen activator: proenzyme, receptor and inhibitors. J. Cell Biol. 104:801–804.
  • Brennan, T. J., and E. N. Olson. 1990. Myogenin resides in the nucleus and acquires high affinity for a conserved enhancer element on heterodimerization. Genes Dev. 4:582–595.
  • Ciliberto, G. Unpublished data.
  • Colantuoni, V., A. Pirozzi, C. Blance, and R. Cortese. 1987. Negative control of liver-specific gene expression: cloned human retinol-binding protein gene is repressed in HeLa cells. EMBO J. 6:631–636.
  • Davis, R. L., P.-F. Cheng, A. B. Lassar, and H. Weintraub. 1990. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 60:733–746.
  • de Groot, R. P., and W. Krujer. 1990. Transcriptional activation by TGF-β mediated by the dyad symmetry element (DSE) and the TPA responsive element (TRE). Biochem. Biophys. Res. Commun. 168:1074–1081.
  • de Wet, J. R., K. V. Wood, Μ. DeLuca, D. R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725–737.
  • Dignam, J. D., R. Μ. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
  • Gorman, C. Μ., G. T. Merlino, Μ. C. Willingham, I. Pastan, and B. Howard. 1982. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl. Acad. Sci. USA 79:6777–6781.
  • Gregor, P. D., Μ. Sawadogo, and R. G. Roeder. 1990. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev. 4:1730–1740.
  • Gutman, A., and B. Wasylyk. 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP1 binding sites. EMBO J. 9:2241–2246.
  • Jones, K. A., J. T. Kadonaga, P. J. Rosenfeld, T. J. Kelly, and R. Tjian. 1987. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48:7989.
  • Kerr, L. D., D. B. Miller, and L. Μ. Matrisian. 1990. TGF-βl inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell 61:267–278.
  • Kim, S.-J., P. Angel, R. Lafyatis, K. Hattori, K. Y. Kim, Μ. B. Sporn, Μ. Karin, and A. B. Roberts. 1990. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10:1492–1497.
  • Kim, S.-J., F. Denhez, K. Y. Kim, J. T. Holt, Μ. B. Sporn, and A. B. Roberts. 1989. Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor-βl autoinduction. J. Biol. Chem. 264:19373–19378.
  • Kim, S.-J., H.-D. Lee, P. D. Robbins, K. Busam, Μ. B. Sporn, and A. Roberts. 1991. Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma susceptibility gene. Proc. Natl. Acad. Sci. USA 88:3052–3056.
  • Laiho, Μ., J. A. DeCaprio, J. W. Ludlow, D. Μ. Livingston, and J. Massagué. 1990. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185.
  • Laiho, Μ., and J. Keski-Oja. 1989. Growth factors in the regulation of pericellular proteolysis. A review. Cancer Res. 49:2533–2553.
  • Laiho, Μ., L. Rönnstrand, J. Heino, J. A. DeCaprio, J. W. Ludlow, D. Μ. Livingston, and J. Massagué. 1991. Control of junB and extracellular matrix protein expression by transforming growth factor-β1 is independent of simian virus 40 T antigen-sensitive growth-inhibitory events. Mol. Cell. Biol. 11:972–978.
  • Laiho, Μ., O. Saksela, P. A. Andreasen, and J. Keski-Oja. 1986. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J. Cell Biol. 103:2403–2410.
  • Leof, E. B., J. A. Proper, A. Scott-Goustin, G. D. Shipley, P. E. DiCorleto, and H. L. Moses. 1986. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor-β: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci. USA 83:2453–2457.
  • Lund, L. R., A. Riccio, P. A. Andreasen, L. S. Nielsen, P. Kristensen, Μ. Laiho, O. Saksela, F. Blasi, and K. Dano. 1987. Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator-inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J. 6:1281–1286.
  • Lyons, R., and H. L. Moses. 1990. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187:467–473.
  • Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Mermod, N., E. A. O’Neill, T. J. Kelly, and R. Tjian. 1989. The proline-rich transcriptional activator of CTF/NF-1 is distinct from the replication and DNA binding domain. Cell 58:741–753.
  • Morrone, G., R. Cortese, and V. Sorrentino. 1989. Post-transcriptional control of negative acute phase genes by transforming growth factor beta. EMBO J. 8:3767–3771.
  • Moses, H. L., E. Y. Yang, and J. A. Pietenpol. 1990. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245–247.
  • Murre, C., P. Schonleber-McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777–783.
  • Nagata, K., R. A. Guggenheimer, and J. Hurwitz. 1983. Specific binding of a cellular DNA replication protein to the origin of replication of adenovirus DNA. Proc. Natl. Acad. Sci. USA 80:6177–6181.
  • Olsen, H. S., S. Lovmand, J. Lovmand, P. Jørgensen, N. O. Kjeldgaard, and F. S. Pedersen. 1990. Involvement of nuclear factor I-binding sites in control of Akv virus gene expression. J. Virol. 64:4152–4161.
  • Olson, E. N. 1990. MyoD family: a paradigm for development? Genes Dev. 4:1454–1461.
  • Pietenpol, J. A., T. J. Holt, R. W. Stein, and H. L. Moses. 1990. Transforming growth factor β1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. USA 87:3758–3762.
  • Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. Μ. Lyons, Μ. R. Pittelkow, K. Münger, P. Μ. Howley, and H. L. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777–785.
  • Prendergast, G. C., L. E. Diamond, D. Dahl, and Μ. D. Cole. 1990. The c-myc-regulated gene mr1 encodes plasminogen activator inhibitor 1. Mol. Cell. Biol. 10:1265–1269.
  • Prendergast, G. C., and E. B. Ziff. 1991. Methylation-sensitive sequence-specific DNA binding by the c-myc basic region. Science 251:186–189.
  • Riccio, A., L. R. Lund, R. Sartorio, A. Lania, P. A. Andreasen, K. Dano, and F. Blasi. 1988. The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene. Nucleic Acids Res. 16:2805–2824.
  • Rizzino, A. 1988. Transforming growth factor-β: multiple effects on cell differentiation and extracellular matrices. Dev. Biol. 130:411–422.
  • Rossi, P., G. Karsenty, A. Roberts, N. S. Roche, Μ. Sporn, and B. de Crombrugghe. 1988. A nuclear factor 1 binding site mediates the transcriptional activation of a type 1 collagen promoter by transforming growth factor-β. Cell 52:405–414.
  • Sawadogo, Μ. 1988. Multiple forms of the human gene-specific transcription factor USF. II. J. Biol. Chem. 263:11994–12001.
  • Sawadogo, Μ. Personal communication.
  • Sawadogo, Μ., Μ. W. Van Dyke, P. D. Gregor, and R. G. Roeder. 1988. Multiple forms of the human gene-specific transcription factor USF. I. J. Biol. Chem. 263:11985–11993.
  • Sollner-Webb, B., and R. H. Reeder. 1979. The nucleotide sequence of the initiation and termination sites for ribosomal RNA transcription in X. laevis. Cell 18:485–499.
  • Sporn, Μ., A. Roberts, L. Μ. Wakefield, and B. de Crombrugghe. 1987. Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell Biol. 105:1039–1045.
  • Westerhausen, D. R., W. E. Hopkins, and J. Billadello. 1991. Multiple transforming growth factor-β-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells. J. Biol. Chem. 266:1092–1100.
  • Wigler, Μ., R. Sweet, G. K. Sim, B. Wold, A. Pellicer, E. Lacy, T. Maniatis, S. Silverstein, and R. Axel. 1979. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16:777–785.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.